Several uncontrolled case series have described atypical subtrochanteric or femoral shaft fractures after long-term bisphosphonate therapy; the presumed mechanism is oversuppression of bone ...

This report provides considerable reassurance that intermediate-term use of bisphosphonates does not elevate risk for atypical femoral fractures. However, at least two concerns remain. First ...

Patients with pain in the hips, thighs or femur should be radiologically assessed, and examined for possible atypical subtrochanteric fracture. The radiographic changes should be examined for ...

Atypical femoral fractures are a potential side effect of the drug. "That's when the endocrinology people worked out that I was just one of the rare people that's had this," Ms May said.

Evaluate if thigh or groin pain develops and consider discontinuing if atypical femur fracture is suspected. Pregnancy (Cat.D): not recommended. Nursing mothers.